ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

IJMDC. 2025; 9(8): 1940-1944


A rare lung disease in rheumatoid arthritis: case report

Hussam A. Alsulmi.



Abstract
Download PDF Post

Background: Pulmonary alveolar proteinosis (PAP) is an uncommon illness characterized by the aberrant accumulation of surfactant lipids and proteins in the lungs. Both autoimmune and secondary PAP have been linked to autoimmune illnesses, such as rheumatoid arthritis (RA).
Case Presentation: A 29-year-old female living in Saudi Arabia was presented to the emergency department with worsening dyspnea for 6 months. A systemic evaluation revealed a considerable history of polyarthritis and early morning stiffness over 4 years. A high-resolution CT scan of the chest was performed, which revealed a diffuse bilateral appearance of a crazy paving pattern. The bronchoalveolar lavage fluid included proteinaceous granular debris that tested positive for Periodic Acid-Schiff. Following the whole lung lavage (WLL), the patient’s health improved dramatically, with oxygen saturation ranging from 90%-93%. According to findings, this patient had PAP together with a newly established seropositive RA. Her quality of life improved with WLL and the start of a brief, low-dose prednisone treatment with hydroxychloroquine.
Conclusion: PAP is rarely related to connective tissue disorders such as RA. It is an important differential diagnosis for interstitial lung disease-RA. The pathophysiology of these relationships is currently poorly understood.

Key words: Pulmonary alveolar proteinosis, rheumatoid arthritis, Anti-GM-CSF antibody, molgramostim, case report







Bibliomed Article Statistics

48
22
26
37
37
7
R
E
A
D
S

24

16

18

16

30

7
D
O
W
N
L
O
A
D
S
101112010203
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.